Possible Innovative Leukemia Therapy Excites Researchers

Possible Innovative Leukemia Therapy Excites Researchers

03.21.13 | By

A new, experimental therapy for Leukemia is very promising, according to a fascinating story on the front page of the New York Times.

Innovative cell therapy using a patient's own stem cells has shown remarkable results in combating and in a few cases eliminating a very deadly, fast moving adult acute lymphoblastic leukemia. A cautious word: the patient population of these tests is small. Obviously, there's a lot of work to do and a lot more tests that have to be run.

One of the principle physicians involved, Dr. Michel Sadelain, director of the Center for Cell Engineering and the Gene Transfer and Gene Expression Laboratory at Memorial Sloan-Kettering Cancer Center in Manhattan, says of the experiments: "we're creating living drugs... its an exciting story that is just beginning."

In addition to possible break-through therapies like that detailed in this story, America's biopharmaceutical research companies are also working on nearly 1,000 new treatments to help fight leukemia, lymphoma and other cancers that are now in either advanced-stage testing of currently being considered for approval.

More On PhRMA — powered by PhRMApedia


Cost in Context